Sign In
Buy NMRD
$0.0002
+0 (+0%)
At Close: Jun 03, 2026
Nemaura Medical: Opportunity In The Consumer-Centered Continuous Glucose Monitoring Market
09:40am, Thursday, 10'th Mar 2022
The Continuous Glucose Monitoring Market is expanding to consumer-centered CGM wellness devices, targeting Type-2 diabetics, prediabetics, and healthy consumers.
Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
08:00am, Friday, 07'th Jan 2022
Loughborough, England, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic d
Nemaura Medical to Present at the Diabetes Technology Society 2021 Conference on November 4, 2021
06:51pm, Wednesday, 03'rd Nov 2021
Loughborough, England, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic d
Nemaura Medical Launches Beta Version of Its Metabolic Health Program
08:30am, Wednesday, 29'th Sep 2021
MiBoKo , a noninvasive glucose sensor utilizing AI mobile application, addresses a substantia l multibillion-dollar market opportunity in healthcare
NMRD Stock: Why It Increased Today
08:49am, Monday, 27'th Sep 2021
The stock price of Nemaura Medical, Inc. (NASDAQ: NMRD) increased by over 4% today. This is why it happened.
Nemaura Medical Announces Commercial Agreement with UK Licensee
08:00am, Monday, 27'th Sep 2021
Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up
Nemaura Medical Inc. (NASDAQ: NMRD) Diabetes, Obesity Solutions Differentiated in Form and Function
08:30am, Friday, 24'th Sep 2021
NEW YORK, Sept. 24, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio -- Nemaura Medical Inc. (NASDAQ: NMRD) announces the availability of a broadcast titled, “Healthcare Technologies Spearheading Modern
Nemaura Medical announce Professor Osama Hamdy Joins their Advisory Board
09:05am, Friday, 17'th Sep 2021
Loughborough, England, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializi
Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021
08:30am, Monday, 16'th Aug 2021
Loughborough, England, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializi
Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021
08:15am, Monday, 12'th Jul 2021
Loughborough, England, July 12, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic d
Nemaura: Wearable Monitoring Patches For Type-2 Diabetics Could Be An Inspired Move
02:55pm, Friday, 02'nd Jul 2021
Nemaura is an intriguing company developing a wearable patch for monitoring of glucose & blood sugar levels by Type-2 and pre-diabetes patients.
Loughborough, England, June 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializi
Nemaura Medical Makes Progress with Advanced Noninvasive Sensors for Diabetes Management and Metabolic Health
08:01am, Monday, 21'st Jun 2021
For millions of diabetic patients worldwide, the reality of constantly having needles pricked into the body for glucose monitoring can be a never-ending nightmare. With over 460 million people current
Nemaura Medical to Present at the LD Micro Virtual Invitational Conference on June 9, 2021
08:05am, Tuesday, 01'st Jun 2021
Loughborough, England, June 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic d
Neumaura Medical, Inc. to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on June 2, 2021
08:05am, Wednesday, 26'th May 2021
Loughborough, England, May 26, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic de
